These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 6092320
1. The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine. De Clercq E. J Antimicrob Chemother; 1984 Aug; 14 Suppl A():85-95. PubMed ID: 6092320 [Abstract] [Full Text] [Related]
2. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU). De Clercq E. Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733 [Abstract] [Full Text] [Related]
3. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase. Grignet-Debrus C, Cool V, Baudson N, Degrève B, Balzarini J, De Leval L, Debrus S, Velu T, Calberg-Bacq CM. Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629 [Abstract] [Full Text] [Related]
4. Baculovirus replication: inhibition of Trichoplusia ni multiple nuclear polyhedrosis virus by [E]-5-(2-bromovinyl)-2'-deoxyuridine. Wang X, Lescott T, De Clercq E, Kelly DC. J Gen Virol; 1983 Jun; 64 (Pt 6)():1221-7. PubMed ID: 6343553 [Abstract] [Full Text] [Related]
8. Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine. De Clercq E, Descamps J, Balzarini J, Fukui T, Allaudeen HS. Biochem J; 1983 May 01; 211(2):439-45. PubMed ID: 6307280 [Abstract] [Full Text] [Related]
9. Antiviral activity of ganciclovir elaidic acid ester against herpesviruses. Andrei G, Snoeck R, Neyts J, Sandvold ML, Myhren F, De Clercq E. Antiviral Res; 2000 Mar 01; 45(3):157-67. PubMed ID: 10771080 [Abstract] [Full Text] [Related]
10. Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine. Harris SA, McGuigan C, Andrei G, Snoeck R, De Clercq E, Balzarini J. Antivir Chem Chemother; 2001 Sep 01; 12(5):293-300. PubMed ID: 11900348 [Abstract] [Full Text] [Related]
11. Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus. Swierkosz EM, Arens MQ, Rivetna KA. J Clin Microbiol; 1985 Mar 01; 21(3):459-61. PubMed ID: 2984249 [Abstract] [Full Text] [Related]
14. The development of BVDU: An odyssey. De Clercq E. Antivir Chem Chemother; 2023 Mar 01; 31():20402066231152971. PubMed ID: 36710501 [Abstract] [Full Text] [Related]
15. Inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells. Balzarini J, De Clercq E. Methods Find Exp Clin Pharmacol; 1989 Jun 01; 11(6):379-89. PubMed ID: 2545982 [No Abstract] [Full Text] [Related]
17. Apoptosis induced by (E)-5-(2-bromovinyl)-2'-deoxyuridine in varicella zoster virus thymidine kinase-expressing cells is driven by activation of c-Jun/activator protein-1 and Fas ligand/caspase-8. Tomicic MT, Friedrichs C, Christmann M, Wutzler P, Thust R, Kaina B. Mol Pharmacol; 2003 Feb 01; 63(2):439-49. PubMed ID: 12527816 [Abstract] [Full Text] [Related]
18. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine. Docherty JJ, Dobson AT, Trimble JJ, Jennings BA. Intervirology; 1991 Feb 01; 32(5):308-15. PubMed ID: 1657822 [Abstract] [Full Text] [Related]
20. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine. De Clercq E, Desgranges C, Herdewijn P, Sim IS, Jones AS, McLean MJ, Walker RT. J Med Chem; 1986 Feb 01; 29(2):213-7. PubMed ID: 3005566 [Abstract] [Full Text] [Related] Page: [Next] [New Search]